IB Net Payout Yields Model

Invest like me - only at Covestor.com

Royal Caribbean: Inflection Point

By -
  •  Royal Caribbean has started generating positive cash flows.
  • The company has a large debt load, but EPS targets top $5 next year due to strong demand.
  • The stock only trades at 11x '23 EPS targets and the cruise line has a path to produce higher earnings.
  • This idea was discussed in more depth with members of my private investing community, Out Fox The Street. Learn More » 

While Royal Caribbean Cruises (NYSE:RCL) has seen their business hit a major inflection point, the stock trades at the yearly lows. Despite the storm clouds dissipating on Covid fears, the market has now shifted to concerns on a recession in spite of pent-up consumer demand. My investment thesis remains ultra-Bullish on the cruise lines with the disconnect between demand and stock valuations rather large at this point.

Read the full article on Seeking Alpha. 

Disclosure: No position mentioned. Please review the disclaimer page for more details. 

Update - June 24

The negatively on this stock was absurd. Carnival only needed to report a solid backlog to watch these cruise line stocks rebound to May levels. 

-Cruise stocks are soaring in Friday midday trading after Carnival Corp.'s (NYSE:CCL) Q2 results showed that it's filling more of its cabins. Occupancy in the quarter rose to 69%, up from 54% in the prior quarter.
-Norwegian Cruise Line (NYSE:NCLH) stock is gaining 11% and Royal Caribbean Cruises (NYSE:RCL) is surging 12%, both stronger moves than Carnival's (CCL) 8.1% increase.
-The significant boost in occupancy came only three days after UBS analyst Robin Farley said investors would "need to see a significant pick up in occupancy from the 50% levels in Q1 (and NCLH even below that) while keeping price above 2019 levels as they have in the quarters since restarting - and for the cruise lines to address some refinancing" before cruise names make much headway.


Finviz Chart

Comments

Post a Comment

Popular posts from this blog

Occidental: Still Producing Too Much Oil

By -
Image
Though oil continues plunging, the oil giants continue producing more. For Q4, Occidental Petroleum (OXY) had roughly flat production. The worst part is that OXY plans to grow production by 2% to 4% in 2016. The stock has held up somewhat strong, but the inability to turn off the spigot remains troubling. Disclosure: No positions mentioned. Please review the disclaimer page for more details. 
Read more

ChargePoint: Low Quality Beat

By -
Image
  ChargePoint beat FQ2'22 revenue estimates, but the losses are mounting. The company guided up FY22 numbers partly due to acquisitions. The stock still trades at an estimated 21x FY23 number leaving limited upside for the stock and reinforcing why venture funds sold 13.8 million shares. Looking for a portfolio of ideas like this one? Members of Out Fox The Street get exclusive access to our model portfolio.  Learn More » After  solid FQ2'22 earnings ,  ChargePoint Holdings  ( CHPT ) has seen a nice bump in the stock. Now investors have to confront the valuation divide and deal with the past insider sales likely leading to future sales on any stock rallies. My  investment thesis  remains very Bearish on the EV charging station stock on any rallies into the mid-$20s. Read the full article on Seeking Alpha.  Disclosure: No position mentioned. Please review the disclaimer page for more details.  Update - Sept. 8 Be cautious when analysts struggle to make the bullish case on expen
Read more

Aurora Cannabis: Deal Or No Deal

By -
Aurora Cannabis was left out of the major deal making in 2018. The cannabis company updated FQ2 guidance to revenues of $50 to $55 million with a continued focus on pure production growth. The stock is down as the market is becoming less impressed with commodity farming operations due to the prime Oregon example. The stock is below key resistance at $5.40 as medical cannabis patient totals failed to impress. As the end of 2018 came and went,   Aurora Cannabis   ( ACB ) was a notable absentee from the deal making in the cannabis market. Just about all of the other major Canadian cannabis players got large investments or signed up powerful partnerships, but the related stocks didn't generally maintain rallies following the deals. Based on the early legalization data in Canada and Oregon, the best option for Aurora Cannabis might actually be selling production capacity while the Canadian market remains hot. Read the full article on Seeking Alpha.  Disclosure: No
Read more